Standardized Outcomes in Nephrology-Glomerular Disease (SONG-GD): establishing a core outcome set for trials in patients with glomerular disease

Simon A Carter¹, Liz Lightstone², Daniel Cattran³, Arvind Bagga⁴, Sean J Barbour⁵, Jonathan Barratt⁶, John Boletis⁷, Dawn Caster⁸, Rosanna Coppo⁹, Fernando C Fervenza¹⁰, Jürgen Floege¹¹, Michelle Hladunewich¹², Jonathan J Hogan¹³, A Richard Kitching¹⁴, Richard Lafayette¹⁵, Ana Malvar¹⁶, Jai Radhakrishnan¹⁷, Brad H Rovin¹⁸, Hong Zhang¹⁹, Talia Gutman²⁰, Martin Howell²⁰, Charlotte Logeman²¹, Jenny I Shen²², Armando Teixeira-Pinto²⁰, Stephen I Alexander²¹, Yeoungjee Cho²³, Jonathan C Craig²⁴, David Harris²⁵, David W Johnson²³, Peter G Kerr¹⁴, Jessica Ryan²⁶, Andrea K Viecelli²⁷, Angela Yee-Moon Wang²⁸, Martin Wilkie²⁹, Nicole Scholes-Robertson²¹, Allison Tong²⁰; SONG-GD Initiative

Affiliations

¹ Sydney School of Public Health, The University of Sydney, Sydney, Australia; Centre for Kidney Research, The Children's Hospital at Westmead, Sydney, Australia. Electronic address: simon.carter@health.nsw.gov.au.
² Faculty of Medicine, Centre for Inflammatory Disease, Imperial College London, London, UK.
³ Faculty of Medicine, University of Toronto, Toronto, Canada; Toronto General Research Institute, Toronto, Canada.
⁴ Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India.
⁵ Department of Medicine, Division of Nephrology, University of British Columbia, Vancouver, Canada.
⁶ Department of Infection, Immunity and Inflammation, University of Leicester, Leicester, UK; John Walls Renal Unit, Leicester General Hospital, Leicester, UK.
⁷ Nephrology Department and Renal Transplantation Unit, Laiko Hospital, Athens, Greece.
⁸ Division of Nephrology, University of Louisville, Louisville, Kentucky, USA.
⁹ Fondazione Ricerca Molinette, Regina Margherita Hospital, Turin, Italy.
¹⁰ Department of Internal Medicine, Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota, USA.
¹¹ Department of Nephrology and Clinical Immunology, RWTH University Hospital, Aachen, Germany.
¹² Faculty of Medicine, University of Toronto, Toronto, Canada; Sunnybrook Health Sciences Centre, Toronto, Canada.
¹³ Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA; Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
¹⁴ Department of Nephrology, Monash Health, Victoria, Australia; Centre for Inflammatory Diseases, Monash University Department of Medicine, Victoria, Australia.
¹⁵ Stanford University Medical Center, Stanford, California, USA; Department of Medicine, Division of Nephrology, Stanford University, Stanford, California, USA.
¹⁶ Nephrology Department, Hospital Fernández, Buenos Aires, Argentina.
¹⁷ Columbia University Medical Center, New York, New York, USA; Division of Nephrology, New York Presbyterian Hospital, New York, New York, USA.
¹⁸ Department of Internal Medicine, Division of Nephrology, Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
¹⁹ Renal Division of Peking University First Hospital, Beijing, China.
²⁰ Sydney School of Public Health, The University of Sydney, Sydney, Australia; Centre for Kidney Research, The Children's Hospital at Westmead, Sydney, Australia.
²¹ Centre for Kidney Research, The Children's Hospital at Westmead, Sydney, Australia.
²² Division of Nephrology and Hypertension, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, California, USA.
²³ Department of Nephrology, Princess Alexandra Hospital, Brisbane, Australia; Australasian Kidney Trials Network, University of Queensland, Brisbane, Australia; Translational Research Institute, Brisbane, Australia.
²⁴ College of Medicine and Public Health, Flinders University, Adelaide, Australia.
²⁵ Westmead Institute for Medical Research, The University of Sydney, Sydney, Australia; Sydney Medical School, The University of Sydney, Sydney, Australia.
²⁶ Department of Nephrology, Monash Health, Victoria, Australia; Department of Medicine, Monash University, Victoria, Australia.
²⁷ Department of Nephrology, Princess Alexandra Hospital, Brisbane, Australia; Australasian Kidney Trials Network, University of Queensland, Brisbane, Australia.
²⁸ Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong, China.
²⁹ Department of Nephrology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.

PMID: 31122702
PMCID: PMC6961704
DOI: 10.1016/j.kint.2019.01.047

Editorial

Standardized Outcomes in Nephrology-Glomerular Disease (SONG-GD): establishing a core outcome set for trials in patients with glomerular disease

Simon A Carter et al. Kidney Int. 2019 Jun.

. 2019 Jun;95(6):1280-1283.

doi: 10.1016/j.kint.2019.01.047.

Authors

Affiliations

¹ Sydney School of Public Health, The University of Sydney, Sydney, Australia; Centre for Kidney Research, The Children's Hospital at Westmead, Sydney, Australia. Electronic address: simon.carter@health.nsw.gov.au.
² Faculty of Medicine, Centre for Inflammatory Disease, Imperial College London, London, UK.
³ Faculty of Medicine, University of Toronto, Toronto, Canada; Toronto General Research Institute, Toronto, Canada.
⁴ Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India.
⁵ Department of Medicine, Division of Nephrology, University of British Columbia, Vancouver, Canada.
⁶ Department of Infection, Immunity and Inflammation, University of Leicester, Leicester, UK; John Walls Renal Unit, Leicester General Hospital, Leicester, UK.
⁷ Nephrology Department and Renal Transplantation Unit, Laiko Hospital, Athens, Greece.
⁸ Division of Nephrology, University of Louisville, Louisville, Kentucky, USA.
⁹ Fondazione Ricerca Molinette, Regina Margherita Hospital, Turin, Italy.
¹⁰ Department of Internal Medicine, Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota, USA.
¹¹ Department of Nephrology and Clinical Immunology, RWTH University Hospital, Aachen, Germany.
¹² Faculty of Medicine, University of Toronto, Toronto, Canada; Sunnybrook Health Sciences Centre, Toronto, Canada.
¹³ Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA; Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
¹⁴ Department of Nephrology, Monash Health, Victoria, Australia; Centre for Inflammatory Diseases, Monash University Department of Medicine, Victoria, Australia.
¹⁵ Stanford University Medical Center, Stanford, California, USA; Department of Medicine, Division of Nephrology, Stanford University, Stanford, California, USA.
¹⁶ Nephrology Department, Hospital Fernández, Buenos Aires, Argentina.
¹⁷ Columbia University Medical Center, New York, New York, USA; Division of Nephrology, New York Presbyterian Hospital, New York, New York, USA.
¹⁸ Department of Internal Medicine, Division of Nephrology, Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
¹⁹ Renal Division of Peking University First Hospital, Beijing, China.
²⁰ Sydney School of Public Health, The University of Sydney, Sydney, Australia; Centre for Kidney Research, The Children's Hospital at Westmead, Sydney, Australia.
²¹ Centre for Kidney Research, The Children's Hospital at Westmead, Sydney, Australia.
²² Division of Nephrology and Hypertension, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, California, USA.
²³ Department of Nephrology, Princess Alexandra Hospital, Brisbane, Australia; Australasian Kidney Trials Network, University of Queensland, Brisbane, Australia; Translational Research Institute, Brisbane, Australia.
²⁴ College of Medicine and Public Health, Flinders University, Adelaide, Australia.
²⁵ Westmead Institute for Medical Research, The University of Sydney, Sydney, Australia; Sydney Medical School, The University of Sydney, Sydney, Australia.
²⁶ Department of Nephrology, Monash Health, Victoria, Australia; Department of Medicine, Monash University, Victoria, Australia.
²⁷ Department of Nephrology, Princess Alexandra Hospital, Brisbane, Australia; Australasian Kidney Trials Network, University of Queensland, Brisbane, Australia.
²⁸ Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong, China.
²⁹ Department of Nephrology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.

PMID: 31122702
PMCID: PMC6961704
DOI: 10.1016/j.kint.2019.01.047

No abstract available

Keywords: chronic kidney disease; clinical trials; core outcome set; glomerulonephritis; outcomes research; patient-centered outcomes.

PubMed Disclaimer

Conflict of interest statement

DISCLOSURE

The authors declare that they have no competing interests.

Figures

**Figure 1.**
Schema for a Standardized Outcomes in Nephrology (SONG) core outcome set for trials, adapted from Tong *et al*.

See this image and copyright information in PMC

References

1. Wetmore JB, Guo H, Liu J, et al. The incidence, prevalence, and outcomes of glomerulonephritis derived from a large retrospective analysis. Kidney Int 2016; 90: 853–860. - PubMed
1. Schmid CH. Outcome Reporting Bias: A Pervasive Problem in Published Meta-analyses. Am J Kidney Dis 2017; 69: 172–174. - PubMed
1. Baigent C, Herrington WG, Coresh J, et al. Challenges in conducting clinical trials in nephrology: conclusions from a Kidney Disease-Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int 2017; 92: 297–305. - PMC - PubMed
1. Tong A, Manns B, Wang AYM, et al. Implementing core outcomes in kidney disease: report of the Standardized Outcomes in Nephrology (SONG) implementation workshop. Kidney International Forthcoming 2018. - PMC - PubMed
1. Tong A, Craig JC, Nagler EV, et al. Composing a new song for trials: the Standardized Outcomes in Nephrology (SONG) initiative. Nephrol Dial Transplant 2017; 32: 1963–1966. - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources
- Europe PubMed Central

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Standardized Outcomes in Nephrology-Glomerular Disease (SONG-GD): establishing a core outcome set for trials in patients with glomerular disease

Affiliations

Standardized Outcomes in Nephrology-Glomerular Disease (SONG-GD): establishing a core outcome set for trials in patients with glomerular disease

Authors

Affiliations

Conflict of interest statement

Figures

References

Publication types

MeSH terms

Grants and funding

LinkOut - more resources

Full Text Sources